These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3670536)

  • 41. Application of lipid microspheres containing prostaglandin E1 ointment to peripheral ischemic ulcers.
    Sakakibara Y; Jikuya T; Mitsui T
    Dermatology; 1997; 195(3):253-7. PubMed ID: 9407173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of complications of peripheral obstructive arterial disease with prostaglandin E1.
    Killion DD; Ambrus JL
    Angiology; 1987 Jul; 38(7):507-13. PubMed ID: 3619123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of the peripheral vascular diseases with prostaglandin].
    Miyauchi Y
    Nihon Rinsho; 1994 Aug; 52(8):2182-6. PubMed ID: 7933609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vasodilating effect and tissue accumulation of prostaglandin E1 incorporated in lipid microspheres on the rat ductus arteriosus.
    Chino Y; Minagawa T; Kohno Y; Fukushima K; Momma K
    Jpn J Pharmacol; 1999 Sep; 81(1):107-14. PubMed ID: 10580378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of prostaglandin E1 or trimethaphan on local cerebral blood flow and carbon dioxide reactivity during cerebral aneurysm surgery.
    Abe K; Yoshiya I
    J Neurosurg Anesthesiol; 1993 Jul; 5(3):143-50. PubMed ID: 8400752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipo-prostaglandin E1 increases immediate arterial maximal flow velocity of free flap in patients undergoing reconstructive surgery.
    Jin SJ; Suh HP; Lee J; Hwang JH; Hong JPJ; Kim YK
    Acta Anaesthesiol Scand; 2019 Jan; 63(1):40-45. PubMed ID: 30058113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic effects of lipo-PGE1 on peripheral artery in patients with diabetic neuropathy: evaluated by two-dimensional color Doppler echography.
    Okuda Y; Mizutani M; Ogawa M; Sone H; Asano M; Tsurushima Y; Morishima Y; Asakura Y; Suzuki S; Isaka M
    Diabetes Res; 1993; 22(2):87-95. PubMed ID: 8205741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of age in determining the effects of lipo-PGE1 infusion on immediate arterial maximal flow velocity in patients with diabetes undergoing free flap surgery for lower extremity reconstruction: A prospective observational study.
    Park JY; Jin SJ; Suh HP; Lee SA; Cho C; Yu J; Hwang JH; Hong JP; Kim YK
    J Plast Reconstr Aesthet Surg; 2020 May; 73(5):885-892. PubMed ID: 31924534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development, Optimization, and Characterization of PEGylated Nanoemulsion of Prostaglandin E1 for Long Circulation.
    Cheng Y; Liu M; Hu H; Liu D; Zhou S
    AAPS PharmSciTech; 2016 Apr; 17(2):409-17. PubMed ID: 26195071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of prostaglandin E1-induced hypotension on carbon dioxide reactivity and local cerebral blood flow after subarachnoid haemorrhage.
    Abe K; Demizu A; Yoshiya I
    Br J Anaesth; 1992 Mar; 68(3):268-71. PubMed ID: 1547050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Neurological Safety of an Epidurally Administered Lipo-PGE1 Agonist in Rats.
    Choi E; Im SM; Yoo HS; Nahm FS; Kim YH; Choe G; Lee PB
    Reg Anesth Pain Med; 2017; 42(1):75-81. PubMed ID: 27922949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Review: recent advances in lipid microsphere technology for targeting prostaglandin delivery.
    Mizushima Y; Hoshi K
    J Drug Target; 1993; 1(2):93-100. PubMed ID: 8069557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of lipo-prostaglandin E1 on random pattern flaps in rabbits.
    Kuwahara H; Sugihara T; Ohura T; Igawa H; Yamamoto Y
    Scand J Plast Reconstr Surg Hand Surg; 1996 Mar; 30(1):23-8. PubMed ID: 8711438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of lipo-prostaglandin E1 on axial pattern flaps in rabbits.
    Kuwahara H; Fazhi Q; Sugihara T; Ohura T; Igawa H; Yamamoto Y
    Ann Plast Surg; 1995 Dec; 35(6):620-6. PubMed ID: 8748345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Echocardiographic evaluation of the ductal morphology in patients with refractoriness to lipo-prostaglandin E1 therapy.
    Takeda N; Hiraishi S; Misawa H; Agata Y; Horiguchi Y; Fujino N; Hirota H; Kawamura S; Ogawa N
    Pediatr Int; 2000 Apr; 42(2):134-8. PubMed ID: 10804727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Somatosensory evoked potentials quantify clinical improvement of cerebral vasospasm after intravenous administration of nimodipine.
    Lipschitz R; Davidson K; Strugo V
    S Afr Med J; 1988 Oct; 74(8):403-5. PubMed ID: 3187819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Actions of prostaglandin E1 on lipopolysaccharide-evoked responses in vivo and in vitro following resuscitated trauma.
    Stewart RM; Fabian TC; McGinty MP; Fabian MJ; Proctor KG
    Shock; 1995 Apr; 3(4):307-14. PubMed ID: 7600198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [New treatment for cerebral vasospasm: fluosol-DA, 20% and improvement of cerebral ischemia].
    Nagasawa S; Naruo Y; Yonekawa Y; Hoshimaru M; Oda Y; Handa H
    Neurol Med Chir (Tokyo); 1982 Aug; 22(8):626-32. PubMed ID: 6183603
    [No Abstract]   [Full Text] [Related]  

  • 59. Therapeutic effects of carbogen inhalation and lipo-prostaglandin E1 in sudden hearing loss.
    Lee HJ; Park CY; Lee JH; Yang HS; Kim JH; Ban MJ; Moon IS
    Yonsei Med J; 2012 Sep; 53(5):999-1004. PubMed ID: 22869484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipo-prostaglandin E1 improves renal hypoxia evaluated by BOLD-MRI in patients with diabetic kidney disease.
    Li ZC; Cai YZ; Tang ZG; Zuo PL; Liu RB; Liu F
    Clin Imaging; 2018; 50():239-242. PubMed ID: 29689479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.